Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 20 04:00PM ET
30.57
Dollar change
-0.38
Percentage change
-1.23
%
Index- P/E43.90 EPS (ttm)0.70 Insider Own0.48% Shs Outstand435.94M Perf Week-2.95%
Market Cap13.33B Forward P/E14.77 EPS next Y2.07 Insider Trans0.00% Shs Float433.89M Perf Month-0.49%
Income304.28M PEG- EPS next Q- Inst Own7.53% Short Float0.75% Perf Quarter20.73%
Sales5.62B P/S2.37 EPS this Y4.47% Inst Trans8.89% Short Ratio4.36 Perf Half Y17.22%
Book/sh11.94 P/B2.56 EPS next Y19.61% ROA2.99% Short Interest3.25M Perf Year18.49%
Cash/sh1.30 P/C23.47 EPS next 5Y-8.00% ROE5.83% 52W Range21.52 - 31.72 Perf YTD12.06%
Dividend Est.0.76 (2.49%) P/FCF44.49 EPS past 5Y-16.85% ROI3.59% 52W High-3.63% Beta0.82
Dividend TTM0.75 (2.45%) Quick Ratio1.11 Sales past 5Y2.86% Gross Margin69.04% 52W Low42.02% ATR (14)0.39
Dividend Ex-DateOct 04, 2024 Current Ratio2.51 EPS Y/Y TTM37.89% Oper. Margin14.74% RSI (14)47.56 Volatility1.02% 0.98%
Employees19551 Debt/Eq0.70 Sales Y/Y TTM2.60% Profit Margin5.41% Recom1.79 Target Price34.01
Option/ShortYes / Yes LT Debt/Eq0.63 EPS Q/Q24.18% Payout120.88% Rel Volume0.75 Prev Close30.95
Sales Surprise0.07% EPS Surprise-4.28% Sales Q/Q3.40% EarningsAug 01 BMO Avg Volume744.07K Price30.57
SMA20-1.72% SMA501.92% SMA20012.46% Trades Volume561,533 Change-1.23%
Date Action Analyst Rating Change Price Target Change
Jul-24-24Initiated Deutsche Bank Buy
Jun-05-24Upgrade UBS Neutral → Buy
Nov-28-23Upgrade Barclays Underweight → Equal Weight
Nov-03-23Upgrade JP Morgan Neutral → Overweight
Oct-31-23Upgrade HSBC Securities Hold → Buy
Oct-13-23Initiated Stifel Hold
Aug-08-23Upgrade UBS Sell → Neutral
Apr-27-23Downgrade HSBC Securities Buy → Hold
Apr-11-23Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-12-22Initiated Citigroup Buy
Sep-18-24 10:00AM
Sep-12-24 10:57AM
Sep-11-24 08:30AM
Sep-10-24 10:00AM
Aug-12-24 11:21AM
01:10PM Loading…
Aug-07-24 01:10PM
Aug-01-24 04:05PM
Jul-30-24 08:00AM
Jul-24-24 09:40AM
Jul-17-24 12:27PM
Jul-16-24 08:00AM
Jul-12-24 08:13AM
Jul-10-24 08:07PM
Jul-09-24 08:00AM
Jul-08-24 08:26PM
12:34PM Loading…
12:34PM
11:16AM
Jul-04-24 01:40PM
01:05PM
Jun-27-24 02:47PM
Jun-26-24 03:00AM
Jun-14-24 01:34PM
Jun-12-24 08:00AM
Jun-08-24 10:08PM
May-20-24 06:00AM
Apr-18-24 07:00AM
Apr-11-24 09:15AM
Apr-08-24 06:00PM
11:27AM
Apr-04-24 11:13AM
08:00AM Loading…
Apr-01-24 08:00AM
07:06AM
Mar-25-24 08:00AM
Mar-13-24 04:30PM
Feb-28-24 12:52PM
10:21AM
08:00AM
Feb-27-24 05:09PM
05:04PM
04:19PM
02:42AM
Feb-21-24 09:40AM
Feb-13-24 08:00AM
Feb-12-24 03:00PM
08:00AM
Feb-10-24 12:03PM
Jan-24-24 09:40AM
Jan-18-24 08:38PM
Jan-14-24 04:00PM
Jan-11-24 07:00AM
Nov-28-23 11:31AM
Nov-27-23 01:33AM
Nov-03-23 06:25PM
Oct-11-23 02:00AM
Oct-05-23 07:06AM
Oct-03-23 05:02AM
Oct-02-23 09:15AM
Sep-29-23 09:40AM
Sep-21-23 08:24PM
Sep-18-23 11:30AM
Sep-13-23 09:40AM
Sep-04-23 09:40AM
09:35AM
Jul-05-23 09:25PM
Jun-17-23 08:00AM
Jun-14-23 05:00PM
Jun-12-23 10:00AM
Jun-07-23 01:10AM
May-16-23 08:00AM
May-02-23 08:00AM
Apr-25-23 09:21AM
Apr-24-23 08:00AM
Apr-14-23 09:40AM
Apr-10-23 07:00PM
Apr-09-23 03:59AM
Mar-29-23 09:40AM
Mar-26-23 03:22AM
Mar-24-23 07:49AM
Mar-23-23 08:00AM
Mar-09-23 07:48AM
01:36AM
Mar-08-23 02:46PM
08:00AM
Mar-07-23 10:00AM
08:00AM
Mar-06-23 09:40AM
08:00AM
Feb-27-23 10:49PM
09:40AM
Feb-24-23 01:05PM
Feb-23-23 12:00PM
12:11AM
Feb-21-23 09:53AM
Jan-30-23 08:00AM
Jan-24-23 02:34PM
Jan-23-23 09:33AM
Jan-12-23 01:05AM
Jan-04-23 08:00PM
Jan-03-23 08:12PM
Dec-16-22 09:21AM
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.